Association of changes in histological severity of non-alcoholic steatohepatitis and changes in patient-reported quality of life | 35903833 | PMC9512481 | Journal | 2022 | 10.1002/hep4.2044 | FLINT, PIVENS | 23138 | Secondary Research |
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. | 25468160 | PMC4447192 | Journal | 2015 | 10.1016/S0140-6736(14)61933-4 | FLINT | Contributing Study | |
The roles of type 2 diabetes and obesity in disease activity and progression of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis | 37933187 | Journal | 2024 | 10.1080/03007995.2023.2279676 | PIVENS, CyNCh, TONIC, FLINT, NAFLD Adult, NAFLD Pediatric | 23059 | Secondary Research |